v3.26.1
Summary of Significant Accounting Policies - Schedule of Components in Equity Investments (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Schedule of Components in Equity Investments [Line Items]    
Investments $ 6,671,060 $ 6,646,056
Evofem warrants, at fair value [Member]    
Schedule of Components in Equity Investments [Line Items]    
Investments 3,160,058  
Evofem F-1 Preferred Stock, net [Member]    
Schedule of Components in Equity Investments [Line Items]    
Investments $ 3,511,002